Purpose
|
VX-680 (Tozasertib, MK-0457) is a pan-Aurora inhibitor, mostly against Aurora A with Kiapp of 0.6 nM in a cell-free assay, less potent towards Aurora B/Aurora C and 100-fold more selective for Aurora A than 55 other kinases. Phase 2.
|
Characteristics
|
Target: Aurora Kinase inhibitor Receptor: Aurora A,Aurora C,Aurora B, FLT3,Bcr-Abl
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99.60?%
|
Formula
|
C23H28N8OS
|
Solubility
|
200 mM in DMSO
|